Vanda Pharmaceuticals Inc (VNDA)
4.88
+0.20
(+4.27%)
USD |
NASDAQ |
May 03, 16:00
5.05
+0.17
(+3.48%)
After-Hours: 20:00
Vanda Pharmaceuticals Price to Book Value: 0.5153 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.5153 |
| May 02, 2024 | 0.4942 |
| May 01, 2024 | 0.5037 |
| April 30, 2024 | 0.5026 |
| April 29, 2024 | 0.5089 |
| April 26, 2024 | 0.4878 |
| April 25, 2024 | 0.473 |
| April 24, 2024 | 0.4815 |
| April 23, 2024 | 0.4889 |
| April 22, 2024 | 0.5068 |
| April 19, 2024 | 0.5396 |
| April 18, 2024 | 0.5248 |
| April 17, 2024 | 0.5533 |
| April 16, 2024 | 0.4276 |
| April 15, 2024 | 0.4287 |
| April 12, 2024 | 0.435 |
| April 11, 2024 | 0.4519 |
| April 10, 2024 | 0.4519 |
| April 09, 2024 | 0.4604 |
| April 08, 2024 | 0.4762 |
| April 05, 2024 | 0.5089 |
| April 04, 2024 | 0.5195 |
| April 03, 2024 | 0.5332 |
| April 02, 2024 | 0.4129 |
| April 01, 2024 | 0.435 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.434 |
| March 27, 2024 | 0.4107 |
| March 26, 2024 | 0.4076 |
| March 25, 2024 | 0.4086 |
| March 22, 2024 | 0.4107 |
| March 21, 2024 | 0.4129 |
| March 20, 2024 | 0.4012 |
| March 19, 2024 | 0.397 |
| March 18, 2024 | 0.396 |
| March 15, 2024 | 0.4023 |
| March 14, 2024 | 0.4012 |
| March 13, 2024 | 0.4055 |
| March 12, 2024 | 0.4097 |
| March 11, 2024 | 0.4229 |
| March 08, 2024 | 0.4086 |
| March 07, 2024 | 0.4034 |
| March 06, 2024 | 0.4129 |
| March 05, 2024 | 0.4371 |
| March 04, 2024 | 0.4509 |
| March 01, 2024 | 0.4868 |
| February 29, 2024 | 0.472 |
| February 28, 2024 | 0.472 |
| February 27, 2024 | 0.4847 |
| February 26, 2024 | 0.4815 |
| February 23, 2024 | 0.4699 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3581
Minimum
Nov 09 2023
3.139
Maximum
May 06 2019
1.415
Average
1.376
Median
Jul 21 2020
Price to Book Value Benchmarks
| ADMA Biologics Inc | 11.49 |
| INVO Bioscience Inc | -- |
| Johnson & Johnson | 5.131 |
| Nektar Therapeutics | 2.201 |
| Invivyd Inc | 1.626 |
Price to Book Value Related Metrics
| PE Ratio | 93.17 |
| PS Ratio | 1.458 |
| Price to Free Cash Flow | 22.62 |
| Price | 4.88 |
| Earnings Yield | 1.07% |
| Market Cap | 280.78M |
| Normalized PE Ratio | 93.17 |